Nobel laureate researcher Shinya Yamanaka

Nobel laureate researcher Shinya Yamanaka

Nobel laureate researcher Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, speaks at a press conference in Kyoto on Dec. 18, 2018. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000146692
  • Registered date
  • 2018/12/18 19:39:27
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2018 Kyodo News
  • Media size
  • 3134 × 1940 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 695.00(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Stockholm water Prize laureate Oki

    Stockholm water Prize laureate Oki

    Taikan Oki, professor of the School of Engineering at the University of Tokyo, speaks during a press conference in Tokyo on March 25, 2024, after winning the Stockholm Water Prize, the world's most prestigious water award given out by Stockholm Water Foundation in cooperation with the Royal Swedish Academy of Sciences.
      The First Fully Automatic Single-cell Proteome Analysis Platform in China

      The First Fully Automatic Single-cell Proteome Analysis Platform in China

      A researcher is watching the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang Province, China, on March 7, 2024. (Photo by Costfoto/NurPhoto)
        The First Fully Automatic Single-cell Proteome Analysis Platform in China

        The First Fully Automatic Single-cell Proteome Analysis Platform in China

        HANGZHOU, CHINA - MARCH 7, 2024 - A researcher watches the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang province, China, March 7, 2024.
          The First Fully Automatic Single-cell Proteome Analysis Platform in China

          The First Fully Automatic Single-cell Proteome Analysis Platform in China

          HANGZHOU, CHINA - MARCH 7, 2024 - A researcher watches the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang province, China, March 7, 2024.
            The First Fully Automatic Single-cell Proteome Analysis Platform in China

            The First Fully Automatic Single-cell Proteome Analysis Platform in China

            HANGZHOU, CHINA - MARCH 7, 2024 - A researcher watches the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang province, China, March 7, 2024.
              The First Fully Automatic Single-cell Proteome Analysis Platform in China

              The First Fully Automatic Single-cell Proteome Analysis Platform in China

              A researcher is watching the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang Province, China, on March 7, 2024. (Photo by Costfoto/NurPhoto)
                The First Fully Automatic Single-cell Proteome Analysis Platform in China

                The First Fully Automatic Single-cell Proteome Analysis Platform in China

                A researcher is watching the results of protein analysis on a fully automated single-cell proteome analysis platform at the Hangzhou International Science and Innovation Center Laboratory of Zhejiang University in Hangzhou, Zhejiang Province, China, on March 7, 2024. (Photo by Costfoto/NurPhoto)
                  The First Fully Automatic Single-cell Proteome Analysis Platform in China

                  The First Fully Automatic Single-cell Proteome Analysis Platform in China

                  An instrument associated with a fully automated single-cell proteome analysis platform is being pictured in the laboratory of Hangzhou International Science and Innovation Center of Zhejiang University in Hangzhou, Zhejiang Province, China, on March 7, 2024. (Photo by Costfoto/NurPhoto)
                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                    (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference on his way to a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,
                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

                      (240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference with experts at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012